Analysis of samples with 100 protein panel.
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new contract opportunity for analysis of samples using a 100 protein panel to support a cardiovascular disease risk research study. The primary objective is to determine whether patterns of metabolites (both endogenous and exogenous) correlate with proposed protein-based predictors of cardiovascular disease risk. The solicitation is expected to be released on May 1, 2026, with an estimated contract award anticipated by September 1, 2026.
The estimated award value for this opportunity ranges from $25,000 to $250,000, with the work classified under NAICS code 541990 (All Other Professional, Scientific, and Technical Services). Interested contractors should direct inquiries to the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov. This is being pursued as a new requirement with no small business set-aside designation.
Forecast text
Study to deermine in the pattern of metabolites correlates with a predictor of cardiovascular disease (CVD) risk. In this case "metabolites" includes endogenous and exogenous metabolites, and "predictor of CVD risk" will be a set of proteins that have been proposed to predict CVD risk.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast